CopyFind
FINGOLIMOD BIOGARAN 0,5 mg, gélule

FINGOLIMOD BIOGARAN 0,5 mg, gélule

Analogs of FINGOLIMOD BIOGARAN 0,5 mg, gélule

Find cheaper analogs and generic equivalents for FINGOLIMOD BIOGARAN 0,5 mg, gélule.

Ingredients

ਸਰਗਰਮ ਤੱਤ: CHLORHYDRATE DE FINGOLIMOD


ਉਤਪਾਦ ਝਲਕ

About FINGOLIMOD BIOGARAN 0

FINGOLIMOD BIOGARAN 0 is a medication containing the active ingredient Fingolimod. Fingolimod, sold under the brand name Gilenya, is an immunomodulating medication, used for the treatment of multiple sclerosis. Fingolimod is a sphingosine-1-phosphate receptor modulator, which sequesters lymphocytes in lymph nodes, preventing them from contributing to an autoimmune reaction.

Key Benefits & Uses

  • Used for: 1 INDICATIONS AND USAGE Fingolimod capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically.
  • Use only as directed on the product label or by a healthcare professional.
  • Follow the authorised product information for dosing and duration of use.

Active Ingredient & Action

Fingolimod, the active ingredient in FINGOLIMOD BIOGARAN 0, is the pharmacologically active substance of this product. 1 INDICATIONS AND USAGE Fingolimod capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in patients 10 years of age and older. Inactive ingredients: not listed in source data.

Important Notes

Always read and follow the label instructions carefully before taking FINGOLIMOD BIOGARAN 0. If you have any underlying medical conditions, are taking other medicines, or are pregnant or breastfeeding, consult a doctor or pharmacist before use. Do not exceed the recommended dose on the package and do not use FINGOLIMOD BIOGARAN 0 for extended periods without medical advice.

Find in Pharmacies

Compare local prices and distance for FINGOLIMOD BIOGARAN 0,5 mg, gélule.

Visitor ratings

Help others by rating how useful this product page is.

No ratings yet — be the first.